These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4540069)

  • 21. Studies of allograft immunity in mice. II. Mechanism of target cell inactivation in vitro by sensitized lymphocytes.
    Mauel J; Rudolf H; Chapuis B; Brunner KT
    Immunology; 1970 Apr; 18(4):517-35. PubMed ID: 5421033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-CD4 IgG2a monoclonal antibody treatment prevents the expansion of T cells in the spleen during murine graft-vs-host disease.
    Noort WA; Benner R; Savelkoul HF
    Transplant Proc; 1995 Feb; 27(1):384-6. PubMed ID: 7879030
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prognostic significance of antilymphocyte antibodies in a perivital kidney allograft].
    Savchenko NE; Levin VI; Buglova SE; Chashinskaia TI
    Urol Nefrol (Mosk); 1984; (4):3-6. PubMed ID: 6382734
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of hematopoietic stem cells by syngeneic lymphocytes.
    Kaulen DR; Golovanova TA; Pyatykhina DP; Khorobrykh VV
    Bull Exp Biol Med; 1974 Aug; 77(2):156-8. PubMed ID: 4547983
    [No Abstract]   [Full Text] [Related]  

  • 25. HLA-DR matching and B-cell crossmatching in renal transplantation.
    Ting A; Williams KA; Morris PJ
    Transplant Proc; 1980 Sep; 12(3):495-501. PubMed ID: 7013181
    [No Abstract]   [Full Text] [Related]  

  • 26. Systematic transfusion in hemodialyzed patients awaiting grafts: kinetics of anti-t and b lymphocyte immunization and its incidence on graft function.
    Soulillou JP; Bignon JD; Peyrat MA; Guimbretiere J; Guenel J
    Transplantation; 1980 Oct; 30(4):285-9. PubMed ID: 7003845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical use of antilymphoblast serum.
    Najarian JS; Merkel FK; Moore GE; Good RA; Aust JC
    Transplant Proc; 1969 Mar; 1(1):460-2. PubMed ID: 5002662
    [No Abstract]   [Full Text] [Related]  

  • 28. Generation of suppressor cells maintains donor-specific tolerance after intrathymic injection of alloantigen.
    Nakafusa Y; Arima T; Goss JA; Flye MW
    Transplant Proc; 1995 Feb; 27(1):128-9. PubMed ID: 7878881
    [No Abstract]   [Full Text] [Related]  

  • 29. Thymus-derived lymphocytes as effectors of cell-mediated immunity to syngeneic and allogeneic transplants in the rat.
    Tucker DF; Dennert G; Lennox ES
    J Immunol; 1974 Oct; 113(4):1302-12. PubMed ID: 4547337
    [No Abstract]   [Full Text] [Related]  

  • 30. Immunologic tolerance to a hapten. 3. Induction of tolerance to trinitrophenyl in B cells in various differentiation states.
    Fidler JM; Golub ES
    J Immunol; 1974 May; 112(5):1891-9. PubMed ID: 4594419
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunologic studies in primates undergoing concordant xenotransplantation as a bridge allotransplantation.
    Shah AS; Itescu S; O'Hair DP; Tugulea S; Kwiatkowski PA; Liu Z; Platt JL; Rose EA; Suciu-Foca N; Michler RE
    Transplant Proc; 1996 Apr; 28(2):745-6. PubMed ID: 8623377
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood transfusions as "transplantation pretreatment": incidence of immunization against unfractionated lymphocytes, T- and B-lymphocytes.
    Fehrman I; Opelz G
    Scand J Urol Nephrol Suppl; 1981; 64():93-9. PubMed ID: 6755690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of simultaneous intrathymic injection of two unrelated cellular alloantigens on rat cardiac allograft survival.
    Shimomura K; Hardy MA; Oluwole SF
    Transplant Proc; 1995 Feb; 27(1):127. PubMed ID: 7878878
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential effects of cyclosporin-A on lymphocyte subpopulations.
    Leapman SB; Filo RS; Smith EJ; Smith PG
    Transplant Proc; 1981 Mar; 13(1 Pt 1):405-9. PubMed ID: 6455796
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone marrow transplantation after antilymphocyte globulin conditioning--split lymphocyte chimerism.
    Mathé G; Schwarzenberg L; Amiel JL; Schneider M; Belpomme D; Jasmin C; Rosenfeld C; Hayat M; de Vassal F; Steresco M
    Transplant Proc; 1972 Dec; 4(4):551-7. PubMed ID: 4566797
    [No Abstract]   [Full Text] [Related]  

  • 36. Antigen binding T and B lymphocytes. I. Differences in cellular specificity and influence of metabolic activity on interaction of antigen with T and B cells.
    Hämmerling GJ; McDevitt HO
    J Immunol; 1974 May; 112(5):1726-33. PubMed ID: 4544797
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum suppressive factor appears to potentiate cardiac allograft survival after portal vein injection of ultraviolet B-irradiated donor spleen cells.
    Yu S; Nakafusa Y; Flye MW
    Transplant Proc; 1993 Feb; 25(1 Pt 1):500-1. PubMed ID: 8438394
    [No Abstract]   [Full Text] [Related]  

  • 38. [Characteristics of T-Suppressors concentrated by elution from an allogeneic cell monolayer].
    Abronina IF; Karaulov AV; Brondz BD
    Biull Eksp Biol Med; 1980 Feb; 89(2):202-5. PubMed ID: 6445215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental myocarditis: in vitro and in vivo studies of lymphocytes sensitized to heart extracts and group A streptococci.
    Friedman I; Laufer A; Ron N; Davies AM
    Immunology; 1971 Feb; 20(2):225-32. PubMed ID: 5548569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte ecology and immunologic tolerance.
    Levey RH
    Transplant Proc; 1973 Mar; 5(1):893-6. PubMed ID: 4572152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.